Patents by Inventor András Simon

András Simon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030032169
    Abstract: In accordance with this invention, an RPE cell membrane associated protein which has a molecular weight of about 32 kd, as determined by SDS-PAGE, has been discovered. This protein, referred to an “p32,” forms an oligomeric protein complex with the previously characterized p63 protein, a component of the membrane receptor for RBP. A nucleic acid molecule which codes for the p32 protein has also been isolated and sequence analysis shows that the p32 protein belongs to the family of short chain alcohol dehydrogenases, and exhibits 11-cis retinol dehydrogenase activity, the enzyme which catalyzes conversion of 11-cis-retinol into 11-cis retinaldehyde.
    Type: Application
    Filed: May 4, 2001
    Publication date: February 13, 2003
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Ulf Eriksson, Andras Simon, Anna Romert
  • Publication number: 20020119543
    Abstract: The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.
    Type: Application
    Filed: November 14, 2001
    Publication date: August 29, 2002
    Inventors: Andras Simon, Ulf Eriksson, Thaddeus P. Dryja, Eliot L. Berson, Hioyuji Yamamoto
  • Patent number: 6399344
    Abstract: Isolated membrane associated proteins which have a molecular weight of from about 30 kD to about 36 kilodaltons as determined by SDS-PAGE, are disclosed. The proteins have cis retinol dehydrogenase activity, such as 9, 11 or 13 cis retinol dehydrogenase activity, or cis activity at more than one position. Other trans-retinol dehydrogenases are also disclosed. Nucleic acid molecules which code for the proteins are also disclosed.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: June 4, 2002
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Ulf Eriksson, Andras Simon, Anna Romert
  • Patent number: 6372463
    Abstract: The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.
    Type: Grant
    Filed: May 6, 1999
    Date of Patent: April 16, 2002
    Assignees: The President & Fellows of Harvard College, Massachusette Eye & Ear Infirmary, Ludwig Institute for Cancer Research
    Inventors: András Simon, Ulf Eriksson, Thaddeus P. Dryja, Eliot L. Berson, Hioyuji Yamamoto
  • Publication number: 20020042116
    Abstract: The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.
    Type: Application
    Filed: June 13, 2001
    Publication date: April 11, 2002
    Inventors: Andras Simon, Ulf Eriksson, Thaddeus P. Dryja, Eliot L. Berson, Hioyuji Yamamoto
  • Patent number: 6358728
    Abstract: The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: March 19, 2002
    Assignees: The President & Fellows of Havard College, Massachusettes Eye & Ear Infirmary, Ludwig Institute for Cancer Research
    Inventors: András Simon, Ulf Eriksson, Thaddeaus P. Dryja, Eliot L. Berson, Hioyuji Yamamoto
  • Patent number: 6280997
    Abstract: In accordance with this invention, an RPE cell membrane associated protein which has a molecular weight of about 32 kd, as determined by SDS-PAGE, has been discovered. This protein, referred to an “p32,” forms an oligomeric protein complex with the previously characterized p63 protein, a component of the membrane receptor for RBP. A nucleic acid molecule which codes for the p32 protein has also been isolated and sequence analysis shows that the p32 protein belongs to the family of short chain alcohol dehydrogenases, and exhibits 11-cis retinol dehydrogenase activity, the enzyme which catalyzes conversion of 11-cis-retinol into 11-cis retinaldehyde.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: August 28, 2001
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Ulf Eriksson, Andras Simon, Anna Romert
  • Patent number: 5972646
    Abstract: In accordance with this invention, an RPE cell membrane associated protein which has a molecular weight of about 32 kd, as determined by SDS-PAGE, has been discovered. This protein, referred to an "p32," forms an oligomeric protein complex with the previously characterized p63 protein, a component of the membrane receptor for RBP. A nucleic acid molecule which codes for the p32 protein has also been isolated and sequence analysis shows that the p32 protein belongs to the family of short chain alcohol dehydrogenases, and exhibits 11-cis retinol dehydrogenase activity, the enzyme which catalyzes conversion of 11-cis-retinol into 11-cis retinaldehyde.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: October 26, 1999
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Ulf Eriksson, Andras Simon, Anna Romert
  • Patent number: 5731195
    Abstract: In accordance with this invention, an RPE cell membrane associated protein which has a molecular weight of about 32 kd, as determined by SDS-PAGE, has now been discovered. This protein, referred to an "p32," forms an oligomeric protein complex with the previously characterized p63 protein, a component of the membrane receptor for RBP. A nucleic acid molecule which codes for the p32 protein has also been isolated and sequence analysis shows that the p32 protein belongs to the family of short chain alcohol dehydrogenases, and exhibits 11-cis retinol dehydrogenase activity, the enzyme which catalyzes conversion of 11-cis-retinol into 11-cis retinaldehyde.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: March 24, 1998
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Andras Simon, Ulf Hellman, Christer Wernstedt, Ulf Eriksson